Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Myeloid 1Lymphoid 1

Conditions

Leukemia, Myelogenous, Chronic, BCR-ABL Positive 4Precursor Cell Lymphoblastic Leukemia-Lymphoma 3Myelodysplastic Syndromes 2Lymphoma, Non-Hodgkin 2Leukemia, Myelomonocytic, Juvenile 2Leukemia, Myeloid, Acute 2Burkitt Lymphoma 2Sarcoma, Myeloid 1Leukemia, Myeloid 1Leukemia, Large Granular Lymphocytic 1Hodgkin Disease 1Blast Crisis 1

Interventions

Peripheral Blood Stem Cell Transplantation 12fludarabine phosphate 11Cyclophosphamide 10Whole-Body Irradiation 9Mycophenolic Acid 9Cyclosporine 8Tacrolimus 5Antilymphocyte Serum 5Methylprednisolone 4Filgrastim 4Thiotepa 3Radiotherapy 3Melphalan 3Carboplatin 3Busulfan 3thymoglobulin 2liposomal amphotericin B 2fludarabine 2Transplantation 2Therapeutics 2Sunitinib 2Psychiatric Rehabilitation 2Pentetic Acid 2Ondansetron 2Morphine 2Interferon-alpha 2In Situ Hybridization, Fluorescence 2Flow Cytometry 2Fentanyl 2Etoposide 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Leukemia, Large Granular Lymphocytic × blinatumomab × Myeloid × Clear all
NCT03849651 2026-06-03

TCRαβ-depleted Progenitor Cell Graft With Additional Memory T-cell DLI, Plus Selected Use of Blinatumomab, in Naive T-cell Depleted Haploidentical Donor Hematopoietc Cell Transplantation for Hematologic Malignancies

St. Jude Children's Research Hospital

Phase 2 Active not recruiting
69 enrolled 17 charts
LymphoidMyeloidOther hematologic neoplasm

Hodgkin Disease, Lymphoma, Non-Hodgkin, Myelodysplastic Syndromes, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Leukemia, Myeloid, Acute, Leukemia, Large Granular Lymphocytic, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Leukemia, Myelomonocytic, Juvenile

Data powered by HemOnc (CC BY 4.0) Colophon âš¡